Delivery Order SPE2DB24D1104-SPE2DB24FXYA0
Award Date 5/14/24
Potential Completion Date 6/5/24
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a delivery order contract valued at $3,518.40 for the supply of NUBEQA 300 MG TABLET 120S. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order (DO) valued at $7,036.80 for the supply of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The contract has a completion date of July 22, 2024 and was awarded on June 28, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of NUBEQA 300 MG TABLET 120S. The contract, valued at $22,925.94, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 25, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $7,641.98 for the supply of NUBEQA 300 MG TABLET 120S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 31, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 120 tablets of the prescription medication NUBEQA 300 MG. The $7,641.98 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of July 22, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The $7,641.98 firm fixed-price delivery order is for NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract is not set aside and has an ultimate completion date of June 27, 2025. Amerisourcebergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUBEQA 300 MG TABLET 120S. The contract has a firm fixed price of $14,051.91 and a period of performance through December 4, 2024. The award is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $7,641.98, is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
- This federal contract award, valued at $10,555.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NUBEQA 300 MG TABLET 120S. The contract is a Firm Fixed Price Delivery Order with a completion date of July 25, 2024. Amerisourcebergen, through its Corporate Office division, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a Delivery Order contract with a Firm Fixed Price pricing type. It has a ceiling value of $3,518.40 and an ultimate completion date of July 22, 2024. The contract was awarded on June 28, 2024 by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract is for the supply of the pharmaceutical product NUBEQA 300 MG TABLET 120S. This award is associated...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB24FXYA0Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,518.40, is a Delivery Order placed under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The contract does not have a set-aside designation.
Generated 8/13/24, 11:51 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 5/14/24 |